For instance, increasing evidence implicates microglial NLRP3 inflammasome activation and subsequent release of IL-1β in ALS pathogenesis (Deora et al., 2020; Holbrook et al., 2021; Moreno-García et al., 2021). This evidence concerns the gene NLRP3 and amyotrophic lateral sclerosis.